NCT07444697Recruiting
"Erectile Function After PCI in MI and Non-MI Patients"
Erectile Function After Percutaneous Coronary Intervention in Myocardial Infarction and Non-Infarction Patients: A Prospective Comparative Study.
Source: ClinicalTrials.gov · Last updated 3 Mar 2026
Brief summary (registry, in English)
The goal of this observational study is to assess changes in patients' erectile function after percutaneous coronary intervention (PCI) using a standard IIEF (International Index of Erectile Function) questionnaire at 1, 3, and 6 months post-PCI. By doing this, we try to compare patients' responses to PCI after having a heart attack and stable angina to see the real effect of myocardial infarction on erectile function status in the long term by comparing it with a very similar group.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 100 (estimated)
- First submitted
- 20 Jan 2026
- Start date
- 15 Jan 2026
- Primary completion date
- 30 Nov 2026
- Lead sponsor
- Kırıkkale University
- Diseases
- Coronary artery disease
- NCT number
- NCT07444697
What you commit to
- Study type: Observational
- Planned participants: 100
- From 15 Jan 2026 to the primary completion date, 30 Nov 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Who the study is looking for
- Male patients aged 30-75 years
- Undergoing successful percutaneous coronary intervention (PCI) for one of the following:
- Acute myocardial infarction (Group 1)
- Stable angina (Group 2)
- Hemodynamically stable after the PCI procedure
- Survival of the index hospitalization
- Ability to provide written informed consent
- Sexually active within the 3 months prior to enrollment
- Willingness and ability to complete follow-up visits and questionnaires at:
- Baseline (post-PCI recovery)
- 3 months
- 6 months Exclusion Criteria
- Known malignancy (active or recently treated)
- Neurological disorders affecting erectile function, including:
- Spinal cord injury
- Multiple sclerosis
- Parkinson's disease
- Uncontrolled diabetes mellitus (HbA1c \> 9%)
- Presence of more than two chronic systemic diseases, such as:
- Severe renal disease
- Severe hepatic disease
- Severe pulmonary disease
- Polypharmacy, defined as chronic use of more than three daily medications
- Absence of sexual activity or lack of a sexual partner
- Refusal or inability to provide informed consent or complete study questionnaires
- Severe psychiatric illness interfering with study participation
- Endocrine disorders, including:
- Untreated hypogonadism
- Thyroid disease
- Major post-PCI complications preventing participation, including:
- Reinfarction
- Stroke
- Heart failure
Age in the registry: 30 years to 75 years · Sex: Male · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The Hospital of Kirikkale Univerity Faculty of Medicine Coordinator of this site? Confirm its status | Kirikkale | Turkey (Türkiye) | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.